(Sharecast News) - Shares in International Biotechnology Trust (IBT) were on the rise on Monday after Swiss pharma giant Novartis snapped up one of its portfolio companies for $12bn in cash.
San Diego-based Avidity Biosciences, which specialising in RNA therapies for serious, genetic neuromuscular diseases, was IBT's eighth-largest holding in the...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE